全文获取类型
收费全文 | 3021篇 |
免费 | 170篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 244篇 |
妇产科学 | 64篇 |
基础医学 | 321篇 |
口腔科学 | 75篇 |
临床医学 | 214篇 |
内科学 | 598篇 |
皮肤病学 | 128篇 |
神经病学 | 149篇 |
特种医学 | 94篇 |
外科学 | 413篇 |
综合类 | 67篇 |
预防医学 | 144篇 |
眼科学 | 185篇 |
药学 | 292篇 |
中国医学 | 14篇 |
肿瘤学 | 177篇 |
出版年
2023年 | 20篇 |
2022年 | 45篇 |
2021年 | 116篇 |
2020年 | 62篇 |
2019年 | 75篇 |
2018年 | 93篇 |
2017年 | 94篇 |
2016年 | 109篇 |
2015年 | 100篇 |
2014年 | 153篇 |
2013年 | 183篇 |
2012年 | 230篇 |
2011年 | 211篇 |
2010年 | 121篇 |
2009年 | 106篇 |
2008年 | 165篇 |
2007年 | 150篇 |
2006年 | 142篇 |
2005年 | 120篇 |
2004年 | 105篇 |
2003年 | 79篇 |
2002年 | 70篇 |
2001年 | 48篇 |
2000年 | 50篇 |
1999年 | 42篇 |
1998年 | 22篇 |
1997年 | 24篇 |
1996年 | 10篇 |
1995年 | 19篇 |
1993年 | 16篇 |
1992年 | 41篇 |
1991年 | 25篇 |
1990年 | 34篇 |
1989年 | 33篇 |
1988年 | 34篇 |
1987年 | 26篇 |
1986年 | 20篇 |
1985年 | 28篇 |
1984年 | 21篇 |
1983年 | 10篇 |
1980年 | 8篇 |
1979年 | 21篇 |
1978年 | 13篇 |
1977年 | 7篇 |
1975年 | 8篇 |
1974年 | 13篇 |
1973年 | 14篇 |
1972年 | 8篇 |
1971年 | 8篇 |
1965年 | 7篇 |
排序方式: 共有3200条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
Vineet Relhan Khushbu Goel Shikha Bansal Vijay Kumar Garg 《Indian journal of dermatology》2014,59(1):15-20
Chronic paronychia is an inflammatory disorder of the nail folds of a toe or finger presenting as redness, tenderness, and swelling. It is recalcitrant dermatoses seen commonly in housewives and housemaids. It is a multifactorial inflammatory reaction of the proximal nail fold to irritants and allergens. Repeated bouts of inflammation lead to fibrosis of proximal nail fold with poor generation of cuticle, which in turn exposes the nail further to irritants and allergens. Thus, general preventive measures form cornerstone of the therapy. Though previously anti-fungals were the mainstay of therapy, topical steroid creams have been found to be more effective in the treatment of chronic paronychia. In recalcitrant cases, surgical treatment may be resorted to, which includes en bloc excision of the proximal nail fold or an eponychial marsupialization, with or without nail plate removal. Newer therapies and surgical modalities are being employed in the management of chronic paronychia. In this overview, we review recent epidemiological studies, present current thinking on the pathophysiology leading to chronic paronychia, discuss the challenges chronic paronychia presents, and recommend a commonsense approach to management. 相似文献
55.
56.
57.
58.
Shveta Bansal Kun Yin Mandagere Vishwanath Helen Doran Roger Laitt Alec Ansons 《Neuro-ophthalmology (Aeolus Press)》2014,38(5):278-280
Neurosarcoidosis is seen in 5–15% of patients with systemic sarcoidosis. The most common cranial nerve presentations are optic neuropathy and facial nerve palsy. The authors present a case of sarcoidosis presenting with a pupil-involving third nerve palsy. The patient responded to corticosteroid therapy with resolution of investigations her cranial nerve palsy but progressed to develop cerebellar signs. This is the first documented case of a pupil-involving third nerve palsy occurring as the first presentation of neurosarcoidosis. Although typically a pupil-involving third nerve palsy necessitates urgent neuroimaging to rule out a posterior communicating artery aneurysm, it is important to recognise inflammatory causes in the differential diagnosis. 相似文献
59.
Kelly L Conrad Adeola R Davis Yuval Silberman Douglas J Sheffler Angela D Shields Sam A Saleh Namita Sen Heinrich JG Matthies Jonathan A Javitch Craig W Lindsley Danny G Winder 《Neuropsychopharmacology》2012,37(10):2253-2266
The alpha2 adrenergic receptor (α2-AR) antagonist yohimbine is a widely used tool for the study of anxiogenesis and stress-induced drug-seeking behavior. We previously demonstrated that yohimbine paradoxically depresses excitatory transmission in the bed nucleus of the stria terminalis (BNST), a region critical to the integration of stress and reward pathways, and produces an impairment of extinction of cocaine-conditioned place preference (cocaine-CPP) independent of α2-AR signaling. Recent studies show yohimbine-induced drug-seeking behavior is attenuated by orexin receptor 1 (OX1R) antagonists. Moreover, yohimbine-induced cocaine-seeking behavior is BNST-dependent. Here, we investigated yohimbine-orexin interactions. Our results demonstrate yohimbine-induced depression of excitatory transmission in the BNST is unaffected by alpha1-AR and corticotropin-releasing factor receptor-1 (CRFR1) antagonists, but is (1) blocked by OxR antagonists and (2) absent in brain slices from orexin knockout mice. Although the actions of yohimbine were not mimicked by the norepinephrine transporter blocker reboxetine, they were by exogenously applied orexin A. We find that, as with yohimbine, orexin A depression of excitatory transmission in BNST is OX1R–dependent. Finally, we find these ex vivo effects are paralleled in vivo, as yohimbine-induced impairment of cocaine-CPP extinction is blocked by a systemically administered OX1R antagonist. These data highlight a new mechanism for orexin on excitatory anxiety circuits and demonstrate that some of the actions of yohimbine may be directly dependent upon orexin signaling and independent of norepinephrine and CRF in the BNST. 相似文献
60.